The utility of brain biomarkers in predicting survival and neurological outcomes in pediatric patients after cardiac arrest: A systematic review and meta-analysis
, 2, 3, 45, 2, 6, 78, 2, 49, 10, 11, 12, 413, 4, 14, 15, 15, 23415
Abstract
Background: Cardiac arrest in children is associated with high morbidity and mortality, primarily due to neurological injury. Biomarkers linked to brain injury, released into circulation from compromised elements of the neurovascular unit, act as significant prognostic indicators in patients suffering from hypoxic-ischemic brain injury (HIBI) subsequent to the restoration of spontaneous circulation (ROSC) after pediatric cardiac arrest. The aim of this systematic review and meta-analysis is to evaluate the prognostic utility of brain injury biomarkers in predicting neurological outcomes and survival in patients following cardiac arrest in the pediatric population.
Methods: Bibliographic databases (PubMed, the Cochrane Library, and Embase) were searched from their inception to November 2024. A random-effect model was used for all analyses.
Results: Our meta-analysis demonstrates significant associations between various biomarkers and survival or neurological outcomes after cardiac arrest. Neuron-specific enolase (NSE) levels were consistently elevated in non-survivors and patients with unfavorable neurological outcomes, with pronounced differences observed on Days 2 and 3 (e.g., Day 3 mean difference: –88.48, 95%CI: –146.77 to –30.19, P = 0.003). Emerging biomarkers, including UCH-L1 and GFAP, showed striking differences, such as elevated UCH-L1 levels on Day 1 (mean difference: –415.41, 95%CI: –474.41 to –356.61, P < 0.001) and GFAP levels exceeding 4000 ng/mL in non-survivors on Day 2 (P < 0.001).
Conclusions: Our findings underscore the significant prognostic value of biomarkers in predicting survival and neurological outcomes following cardiac arrest. Neuron-specific enolase (NSE) consistently demonstrated its reliability across multiple time points, while emerging biomarkers like UCH-L1 and GFAP showed promising potential for early outcome stratification.
Keywords: brain markersneuron-specific enolaseS100β proteinsurvivalcardiac arrestmeta-analysis
References
- Garbin S, Easter J. Pediatric Cardiac Arrest and Resuscitation. Emerg Med Clin North Am. 2023; 41(3): 465–484.
- Topjian AA, de Caen A, Wainwright MS, et al. Pediatric Post-Cardiac Arrest Care: A Scientific Statement From the American Heart Association. Circulation. 2019; 140(6): e194–e233.
- Sandroni C, Cronberg T, Sekhon M. Brain injury after cardiac arrest: pathophysiology, treatment, and prognosis. Intensive Care Med. 2021; 47(12): 1393–1414.
- Kurek K, Swieczkowski D, Pruc M, et al. Predictive Performance of Neuron-Specific Enolase (NSE) for Survival after Resuscitation from Cardiac Arrest: A Systematic Review and Meta-Analysis. J Clin Med. 2023; 12(24).
- Czerwińska-Jelonkiewicz K, Wood A, Bohm A, et al. Association between dose of catecholamines and markers of organ injury early after out-of-hospital cardiac arrest. Cardiol J. 2021 [Epub ahead of print]; 30(6): 946–956.
- Meyer-Szary J, Jaguszewski M, Smereka J, et al. Impact of COVID-19 on pediatric out-of-hospital cardiac arrest in the Masovian region. Disaster and Emergency Medicine Journal. 2021; 6(4): 183–185.
- Hoiland RL, Rikhraj KJK, Thiara S, et al. Neurologic Prognostication After Cardiac Arrest Using Brain Biomarkers: A Systematic Review and Meta-analysis. JAMA Neurol. 2022; 79(4): 390–398.
- Fink EL, Berger RP, Clark RSB, et al. Exploratory study of serum ubiquitin carboxyl-terminal esterase L1 and glial fibrillary acidic protein for outcome prognostication after pediatric cardiac arrest. Resuscitation. 2016; 101: 65–70.
- Kurek K, Tomaszewska M, Pruc M, et al. Role of neuron-specific enolase as a prognostic marker in pediatric cardiac arrest. Am J Emerg Med. 2024; 76: 258–260.
- Bangshøj J, Liebetrau B, Wiberg S, et al. The Value of the Biomarkers Neuron-Specific Enolase and S100 Calcium-Binding Protein for Prediction of Mortality in Children Resuscitated After Cardiac Arrest. Pediatr Cardiol. 2022; 43(7): 1659–1665.
- Hoiland RL, Ainslie PN, Wellington CL, et al. Brain Hypoxia Is Associated With Neuroglial Injury in Humans Post-Cardiac Arrest. Circ Res. 2021; 129(5): 583–597.
- Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ. 2021; 372(n71).
- Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010; 25(9): 603–605.
- Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005; 5: 13.
- Higgins JPT, Altman DG, Gøtzsche PC, et al. Cochrane Bias Methods Group, Cochrane Statistical Methods Group. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011; 343: d5928.
- Elsalam AA, AboElezz A, El-Bendary A, et al. Serum S100B protein as a prognostic biomarker for neurological outcome after in-hospital cardiac arrest in children. Tanta Medical Journal. 2018; 46(2): 133.
- Anetakis KM, Gedela S, Kochanek PM, et al. Association of EEG and Blood-Based Brain Injury Biomarker Accuracy to Prognosticate Mortality After Pediatric Cardiac Arrest: An Exploratory Study. Pediatr Neurol. 2022; 134: 25–30.
- El-Seify M, Shata MO, Salaheldin S, et al. Evaluation of Serum Biomarkers and Electroencephalogram to Determine Survival Outcomes in Pediatric Post-Cardiac-Arrest Patients. Children (Basel). 2023; 10(2).
- Fink EL, Berger RP, Clark RSB, et al. Serum biomarkers of brain injury to classify outcome after pediatric cardiac arrest*. Crit Care Med. 2014; 42(3): 664–674.
- Fink EL, Kochanek PM, Panigrahy A, et al. Personalizing Outcomes After Child Cardiac Arrest (POCCA) Investigators. Association of Blood-Based Brain Injury Biomarker Concentrations With Outcomes After Pediatric Cardiac Arrest. JAMA Netw Open. 2022; 5(9): e2230518.
- Kirschen MP, Yehya N, Graham K, et al. Circulating Neurofilament Light Chain Is Associated With Survival After Pediatric Cardiac Arrest. Pediatr Crit Care Med. 2020; 21(7): 656–661.
- Kramer P, Miera O, Berger F, et al. Prognostic value of serum biomarkers of cerebral injury in classifying neurological outcome after paediatric resuscitation. Resuscitation. 2018; 122: 113–120.
- Lee YY, Choi I, Lee SJ, et al. Clinical Significance of Gray to White Matter Ratio after Cardiopulmonary Resuscitation in Children. Children (Basel). 2022; 9(1).
- Topjian AA, Lin R, Morris MC, et al. Neuron-specific enolase and S-100B are associated with neurologic outcome after pediatric cardiac arrest. Pediatr Crit Care Med. 2009; 10(4): 479–490.
- Shinozaki K, Oda S, Sadahiro T, et al. Serum S-100B is superior to neuron-specific enolase as an early prognostic biomarker for neurological outcome following cardiopulmonary resuscitation. Resuscitation. 2009; 80(8): 870–875.
- Shahim P, Pham DL, van der Merwe AJ, et al. Serum NfL and GFAP as biomarkers of progressive neurodegeneration in TBI. Alzheimers Dement. 2024; 20(7): 4663–4676.
- Mondello S, Palmio J, Streeter J, et al. Ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) is increased in cerebrospinal fluid and plasma of patients after epileptic seizure. BMC Neurol. 2012; 12: 85.
- El Husseini N, Katzan IL, Rost NS, et al. American Heart Association Stroke Council; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Radiology and Intervention; Council on Hypertension; and Council on Lifestyle and Cardiometabolic Health. Cognitive Impairment After Ischemic and Hemorrhagic Stroke: A Scientific Statement From the American Heart Association/American Stroke Association. Stroke. 2023; 54(6): e272–e291.
